Aprea Therapeutics
APRE
APRE
23 hedge funds and large institutions have $3.07M invested in Aprea Therapeutics in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
-3
Holders Change %
-11.54%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
6
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
$107K |
| 2 |
SCM
Sio Capital Management
New York
|
$472K |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
$26.2K |
| 4 |
LPL Financial
San Diego,
California
|
$28.8K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
$852 |
